Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia
- PMID: 15863205
- DOI: 10.1016/j.leukres.2004.11.014
Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia
Abstract
Hypermethylation of CpG islands is a common mechanism by which tumor suppressor genes are inactivated. The tumor suppressor gene p15(INK4b) is important component of cell cycles, whereas E-cadherin gene is often termed a metastasis suppressor gene. We have studied the feasibility of detecting tumor-associated aberrant p15(INK4b) and E-cadherin methylation in acute myeloid leukemia (AML) using methylation-specific PCR. Aberrant methylation of p15(INK4b) was detected in 31 of 61 (51%) AML patients. On the other hand, E-cadherin hypermethylation was detected in 36 of 61 (56%) AML patients. We have examined the methylation pattern of these genes and the prognosis in AML patients using a log-rank test. Methylation of p15(INK4b) gene significantly correlated with prognosis (p=0.0012), and methylation of E-cadherin gene more significantly correlated with prognosis (p=0.0004). When both were methylated, there was even more significant unfavorable prognosis compared to either of the methylated genes (p<0.0001). We interpret these data to mean that dysfunction of the cell cycle and/or the cell-cell adhesion molecule plays a role in the pathogenesis of acute myeloid leukemia and that analysis of the methylation of p15(INK4b) and E-cadherin genes can provide clinically important evidence on which to base treatment.
Similar articles
-
Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.Chin Med J (Engl). 2002 Jul;115(7):987-90. Chin Med J (Engl). 2002. PMID: 12150726
-
Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.Int J Oncol. 2001 Aug;19(2):277-81. Int J Oncol. 2001. PMID: 11445839
-
Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.Cancer Res. 1999 Aug 1;59(15):3730-40. Cancer Res. 1999. PMID: 10446989
-
[Abnormality of p15(INK4b) gene and myelodysplastic syndrome].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002 Aug;10(4):362-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002. PMID: 12513775 Review. Chinese.
-
Tumor suppressor genes in normal and malignant hematopoiesis.Oncogene. 2002 May 13;21(21):3475-95. doi: 10.1038/sj.onc.1205322. Oncogene. 2002. PMID: 12032783 Review.
Cited by
-
Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells.Mol Cell Biochem. 2012 Jan;359(1-2):245-61. doi: 10.1007/s11010-011-1019-7. Epub 2011 Aug 13. Mol Cell Biochem. 2012. PMID: 21842375
-
A study on DNA methylation status in promoter region of p15 gene in patients of acute myeloid leukemia and myelodysplastic syndrome.Med J Armed Forces India. 2021 Jul;77(3):337-342. doi: 10.1016/j.mjafi.2021.04.014. Epub 2021 Jun 26. Med J Armed Forces India. 2021. PMID: 34305288 Free PMC article.
-
p15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressor.Blood Cells Mol Dis. 2013 Apr;50(4):227-31. doi: 10.1016/j.bcmd.2013.01.006. Epub 2013 Feb 9. Blood Cells Mol Dis. 2013. PMID: 23403260 Free PMC article. Review.
-
The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.Amino Acids. 2014 Mar;46(3):585-94. doi: 10.1007/s00726-013-1485-1. Epub 2013 Mar 19. Amino Acids. 2014. PMID: 23508577 Free PMC article.
-
Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.EXCLI J. 2014 Aug 26;13:954-76. eCollection 2014. EXCLI J. 2014. PMID: 26417314 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical